Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Oct 29;10(10):e0140734.
doi: 10.1371/journal.pone.0140734. eCollection 2015.

Comparison of NK-1 Receptor Antagonist (Maropitant) to Morphine as a Pre-Anaesthetic Agent for Canine Ovariohysterectomy

Affiliations

Comparison of NK-1 Receptor Antagonist (Maropitant) to Morphine as a Pre-Anaesthetic Agent for Canine Ovariohysterectomy

Megan Marquez et al. PLoS One. .

Abstract

Objective: To compare the NK-1 receptor antagonist maropitant to morphine during and after surgery in dogs undergoing ovariohysterectomy (OHE).

Methods: 30 healthy female dogs were randomly divided to receive either a pre-anaesthetic dose of morphine (0.5 mg/kg SQ) or maropitant (1 mg/kg, SQ) prior to OHE. Anaesthesia was induced with propofol and maintained with isoflurane. Expired isoflurane concentration, heart rate (HR), systolic arterial pressure (SAP) and respiratory rate were measured. Post-operative pain scores and appetite were evaluated during the recovery period. Rescue analgesia (morphine 0.1 mg/kg IV) was administered as needed post-operatively based on blinded pain score assessments.

Results: Although clinically comparable; during surgical stimulation, the maropitant group had lower HR (108±18 vs 115±24 bpm; p = 0.04), lower SAP (114±23 vs 125±23 mmHg; p = 0.003) and required slightly lower percent of isoflurane anaesthetic (1.35±0.2 vs 1.51±0.4%; p = 0.005), when compared to the morphine group. In the recovery period, the maropitant group had lower pain scores at extubation (1.7±0.7 vs 3.4±2.3; p = 0.0001) and were more likely to eat within 3 hours after extubation (64.7 vs 15.3%). However, post-operative rescue analgesia requirements were similar between groups. All other measured parameters were similar between groups. The overall difference observed between groups was small and all monitored and measured parameters were within the expected range for anesthetized dogs.

Clinical significance: No major differences in cardiorespiratory parameters or anaesthetic requirements were observed between maropitant and morphine when used as a pre-anesthetic agent for OHE. Further studies are necessary to fully elucidate the benefits of maropitant as a pre-anaesthetic agent for canine OHE.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have the following interests. The pharmaceutical company Zoetis provided a small fund as an incentive to include dogs in the study (veterinary clinical trial). There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.

Figures

Fig 1
Fig 1. Physiologic parameters and expired isoflurane anesthesia concentration prior to and during ovariohysterectomy in dogs pre-medicated with morphine or maropitant.
White bars are the baseline parameters obtained prior to surgery. Dashed bars are the averaged parameters obtained during OHE. HR = heart rate, SAP = systolic arterial blood pressure, RR = respiratory rate, Exp Iso = expired isoflurane concentration. Data is presented as mean ± SD. Significant values p≤0.05 & 0.01are depicted with * & ** respectively. Comparison between baseline parameters (white bars) and values obtained during OHE surgical stimulation (dashed bars) are depicted on top of the dashed bars. All other comparisons are indicated within the brackets.

References

    1. Sakurada T, Katsumata K, Yogo H, Tan-No K, Sakurada S, Ohba M, et al. The neurokinin-1 receptor antagonist, sendide, exhibits antinociceptive activity in the formalin test. Pain. 1995; 60: 175–80. - PubMed
    1. Laird JM, Olivar T, Roza C, De Felipe C, Hunt SP, Cervero F. Deficits in visceral pain and hyperalgesia of mice with a disruption of the tachykinin NK1 receptor gene. Neuroscience. 2000; 98: 345–52. - PubMed
    1. Ruggieri MR, Filer-Maerten S, Hieble JP, Hay DW. Role of neurokinin receptors in the behavioral effect of intravesical antigen infusion in guinea pig bladder. J Urol. 2000; 164: 197–202. - PubMed
    1. Laird J. Gut feelings about tachykinin NK1 receptor antagonists. Trends Pharmacol Sci. 2001; 22: 169 - PubMed
    1. Okano S, Ikeura Y, Inatomi N. Effects of tachykinin NK1 receptor antagonists on the viscerosensory response caused by colorectal distention in rabbits. J.Pharmacol Exp Ther. 2002; 300: 925–931. - PubMed

Publication types